Merck (MRK) Other Working Capital Changes (2009 - 2026)
Merck's (MRK) quarterly Other Working Capital Changes came in at -$222.0 million in Q1 2011, down 237.89% year-over-year from $161.0 million in Q1 2010, and down 233.33% quarter-over-quarter from -$66.6 million in Q4 2010.
Analysis
Merck (MRK) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Other Working Capital Changes for 3 consecutive years, with -$222.0 million the latest figure, recorded in Q1 2011.
- On a quarterly basis, Other Working Capital Changes fell 237.89% year-over-year to -$222.0 million in Q1 2011; TTM through Mar 2011 was -$6.0 million, a 98.71% increase from a year earlier, with the FY2010 full-year figure at $377.0 million, up 170.47% from the prior year.
- Other Working Capital Changes was -$222.0 million for Q1 2011 at Merck, down from -$66.6 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.7 billion in Q1 2025 and troughed at -$2.6 billion in Q3 2024.
- A 5-year average of $538.9 million and a median of $488.5 million in 2023 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 185.85% in 2010, down 1700.0% in 2010.
- Over 3 years, Other Working Capital Changes stood at -$3.7 million in 2009, then slumped by 1700.0% to -$66.6 million in 2010, then slumped by 233.33% to -$222.0 million in 2011.
- The last three Other Working Capital Changes figures came in at -$222.0 million (Q1 2011), -$66.6 million (Q4 2010), and $6.6 million (Q3 2010), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -423.00 Mn |
| Jun 30, 2026 | -423.00 Mn |
| Mar 31, 2026 | 1.61 Bn |
| Mar 31, 2026 | 1.61 Bn |
| Dec 31, 2025 | -1.35 Bn |
| Dec 31, 2025 | -1.35 Bn |
| Sep 30, 2025 | -1.31 Bn |
| Sep 30, 2025 | -1.31 Bn |
| Jun 30, 2025 | 2.26 Bn |
| Jun 30, 2025 | 2.26 Bn |
| Mar 31, 2025 | 3.71 Bn |
| Mar 31, 2025 | 3.71 Bn |
| Dec 31, 2024 | -396.00 Mn |
| Dec 31, 2024 | -396.00 Mn |
| Sep 30, 2024 | -2.58 Bn |
| Sep 30, 2024 | -2.58 Bn |
| Jun 30, 2024 | 1.01 Bn |
| Jun 30, 2024 | 1.01 Bn |
| Mar 31, 2024 | 3.38 Bn |
| Mar 31, 2024 | 3.38 Bn |